yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
Red Hat
The Opening of Virtualization
User Environment Management – The Third Layer of the Desktop
Cloud Computing for Business Agility
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Return on Assests: Bringing Visibility to your SOA Strategy
Managing Hybrid Endpoint Environments
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
How Can AJAX Improve Homeland Security?
Beyond Widgets: What a RIA Platform Should Offer
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
Today's Top SOA Links

InSightec completes additional financing round of $30.9 million
--Board of Directors appoints James Davis as new CEO, Tom Gentile appointed as Chairman of Board--

TIRAT CARMEL, Israel, Dec. 9, 2012 /PRNewswire/ -- InSightec Ltd. announced that it has completed its Series C financing totaling $30.9 million. In parallel, the Board of Directors has appointed Mr. James (Jim) Davis as the new Chief Executive Officer. Mr. Tom Gentile, President and CEO of GE Healthcare Systems, has been appointed Chairman of the Board of Directors. Dr. Jackob (Kobi) Vortman, who has founded and shepherded the company since its inception, will continue his role as President and also step into a newly created role of Chief Technology Officer, responsible for R&D, Regulatory Affairs and Operations. 

Jim Davis joins InSightec after 11 years with GE Healthcare. Jim was Vice President & General Manager of the MRI business for 5 years, and also served as VP & GM of the US Diagnostic Imaging Commercial Organization for 3 years. Prior to that Jim worked in GE Aviation for 10 years.  Jim also spent 4 years with McKinsey & Co., a global management consulting firm.  He has also been a Director of InSightec for the past 3 years.

"I am delighted to be joining InSightec at this critical juncture.  With our 2nd FDA approval for pain palliation of bone metastases and CE marking for neurological disorders now in hand, the future is extremely bright for patients and for InSightec," said Mr. Davis. "InSightec has pioneered an entirely new industry around a breakthrough therapy platform that uses MRI to guide and control high intensity ultrasound waves to ablate tissue. ExAblate offers patients a completely safe and non-invasive therapeutic option to traditional surgery, minimally invasive therapies or radiation. This option not only provides patients with shorter recovery times, but lowers the cost of care at a time when healthcare systems around the globe are under tremendous stress. The new investment will allow us to expand our global reach as well as continuing research and development and clinical studies." 

Dr. Vortman added:  "We are very happy to welcome Jim on board. He has contributed greatly to the company as a member of the Board of Directors, and we believe that he brings unique knowledge of the medical market, a deep understanding of the global marketplace, experience in international business, plus commercial, clinical and technical skills to help InSightec achieve widespread awareness and clinical adoption of this technology."

The Series C financing round includes an investment of $27.6 million by GE Healthcare and $3.3 million by other investors.

"With this additional investment GE and the other investors have renewed their longstanding commitment to the future of InSightec and focused ultrasound technology," said Tom Gentile, InSightec's new chairman of the board." InSightec continues to demonstrate its leadership and ability to deliver clinically proven, safe and effective therapy systems and creating non-invasive acoustical surgery centers used by multi-disciplinary groups of physicians for multiple clinical disorders."

InSightec will open US commercial offices in Southeastern Wisconsin, where Jim Davis will be located. The R&D and Operations teams will continue to operate in Israel.

InSightec Ltd. is privately held by Elbit Imaging, General Electric, and MediTech Advisors. Founded in 1999 InSightec developed ExAblate to transform MR-guided Focused Ultrasound (MRgFUS) into a clinically viable technology. ExAblate has won several awards for innovation and its potential to help mankind including The Wall Street Journal Technology Innovation Awards and the European Union's IST grand prize. TIME magazine recently named Focused Ultrasound as "one of 50 best inventions".  For more information please visit:

Media contact:

Lynn Golumbic
011 972 4 813 1380

SOURCE InSightec Ltd.

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Web 2.0 Latest News
Intuit uses deep-data analytics to gain a 360-degree view of its TurboTax application's users’ behavior and preferences for rapid applications improvements. The next BriefingsDirect big-data innovation case study highlights how Intuit uses deep-data analytics to gain a 360-degree view...
Certain CIOs for incomprehensible reasons keep off their cloud transformation projects several key IT disciplines including Enterprise Architecture (EA), IT Service Management (ITSM) and most importantly Project Management. Do they consider them obsolete? useless? irrelevant? ITaaS St...
In today’s pharmaceutical supply chain, counterfeit activity is thriving. As pharma companies have expanded target markets and outsourced production over the last decade, the supply chain has become increasingly global, virtual, and vulnerable. Illicit activity has thrived, and patient...
Here’s the thing: as sure as we’ll have another record-setting year for NFL streaming, you can also be sure that apps will fail and streaming services will go down. Whether you are dabbling in streaming or diving in whole-hog, you need to know what to do to give your users the most rel...
This is how a typical software product lifecycle works : You gather requirements, build a prototype, detail out the architecture and design, develop the product, test it, deploy the product, handle migration and maintenance and ensure product support. This is a closed loop where the Pr...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)!

Advertise on this site! Contact advertising(at)! 201 802-3021

SYS-CON Featured Whitepapers